drugset / Trial / NCT00713661

Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)

NCT00713661

Phase 2 Completed 25 enrolled Nycomed
NaSingle-groupOpen-labelTreatment

Summary

The primary objective is to evaluate if the application of TachoSil® on a colorectal anastomosis is feasible and safe. The secondary objective is to establish and describe optimal application methods to be used for educational purposes in future trials.

Timeline

Start
2008-06
Primary completion
2009-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject TachoSil Other / unclassified Topical

Indications

No indication recorded.